Revenue
2022
2023
2024
2025
Indaptus Therapeutics, Inc. (INDP)
Price$1.19Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2021
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $9.3M | $7.3M | $7.6M | $6.3M | $2.5M | $2.7M |
| Operating expenses | $19.8M | $15.4M | $16.4M | $14.9M | $7.7M | $3.6M |
| Operating income | −$19.8M | −$15.4M | −$16.4M | −$14.9M | −$7.7M | −$3.6M |
| EBITDA | −$19.8M | −$15.4M | −$16.4M | −$14.9M | −$7.7M | −$3.6M |
| Net income | −$20.8M | −$15.0M | −$15.4M | −$14.3M | −$7.7M | −$3.6M |
| Basic EPSper basic share | -$21.58 | -$44.96 | -$51.24 | -$48.44 | -$52.92 | -$51.52 |
| Diluted EPSper diluted share | -$21.58 | -$44.96 | -$51.24 | -$48.44 | -$52.92 | -$51.52 |
Owners
Reported shareholders
≈31.51%of listed shares
Yao Yun41.99M shares · Mar 23, 2026
View holders
| Holder | % owned |
|---|---|
Yao Yun | ≈31.51%41.99M shares |
SINO LION VENTURES Ltd | ≈29.19%38.9M shares |
Dai Junyi | ≈8.44%11.25M shares |
Meckler Jeffrey A | ≈0.17%229.93K shares |
HRT FINANCIAL LP | 0.15%206.08K shares |
Newman Michael James | ≈0.08%101.07K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.04%56.47K shares |
Linscott Walt Addison | ≈0.04%54.43K shares |
JANE STREET GROUP, LLC | 0.04%53.81K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.03%33.65K shares |
Sassi Nir | ≈0.02%26.76K shares |
Ben-Tzvi Avraham | ≈0.02%25.1K shares |
McMurdo Matthew Charles | ≈0.02%25K shares |
VANGUARD FIDUCIARY TRUST CO | 0.01%13.97K shares |
MILLENNIUM MANAGEMENT LLC | <0.01%11.59K shares |
MORGAN STANLEY | <0.01%8.94K shares |
UBS Group AG | <0.01%478 shares |
SBI Securities Co., Ltd. | <0.01%17 shares |
Percentages use 133.24M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 23, 2026Form 4 | Lazar David E.Director | SellSeries AAA Convertible Non-Redeemable Preferred Stock · derivative | 700.0K | — | — | 0 |
| Mar 23, 2026Form 4 | Lazar David E.Director | SellSeries AA Convertible Non-Redeemable Preferred Stock · derivative | 196.8K | — | — | 103.2K |